K. Leela Prasad Babu, M. Venkata Subbaiah, V. Harika, K. Sudha Rani


Liver disorders constitute about 10 % of all diseases. Since the diagnosis of liver disorders is so difficult, identification of its
demographics is of great importance in present health scenario to understand more about diseases. The objective of this study is
to assess the prescribing pattern of drugs used in various liver disorders. This was a prospective observational study carried out for
a period of 6 months in general medicine outpatient, inpatient and ICU departments of RIMS tertiary care teaching hospital,
Kadapa. Out of 150 patients with hepatic disorders, 120 were diagnosed at admission and 30 were diagnosed to have hepatic
impairment during a hospital stay. Among them 120 were males and 30 were females. Antibiotics were the most commonly
prescribed drugs. Majority of patients were not affected by drug interactions, errors including prescribing errors were minimally
noted. It is the responsibility of a clinical pharmacist to communicate physician regarding the patients health conditions, drug
utilization, and their problems, which improves the community health status.


Liver Disorders, Hepatic Impairment, Prescribing Pattern.

Full Text:



Miner Pirmohamed; Prescribing in liver disease; MEDICINE; Liver disorders; volume 39, issue 9, page no-541-44.

Bhanu Prakash Kolasani etal;Prescribing pattern of drugs in patients with alcoholic liver disease in a tertiary care teaching hospital;National Journal of Physiology, Pharmacy,and Pharmacology; Vol 7, Issue 5, 2017,page no-538-44.

S.K.Sarinetal.., e-WGN Expert Point of View Articles collection: Global Burden of Liver Disease: A True burden on health sciences and economies!!

Sonia Ratibetal, liver cirrhosis in England—anobservational study: are we measuringits burden occurrence correctly? BMJ Open access 2017; page no-1-7.

Meenu Vijayan etal;Clinical Profile and Prescribing Pattern of Cirrhosis in a Tertiary Care Hospital;Indian Journal of Pharmacy Practice, Vol 7, Issue 3, Jul–Sep 2014;page no-69-74.

Hemang Suthar etal; a Clinical profile of cases of alcoholic liver disease; International Journal of Medical Science and Public Health | 2013 | Vol 2 | Issue 2; page no-394-98.

Jürgen Rehmetal; Global burden of disease and injury and economic costattributable to alcohol use and alcohol-use disorders; Vol 373 June 27, 2009; page no-2223-2233.


Keith G. Tolman; Liver Safety in Patients with Type 2Diabetes Treated with Pioglitazone; Drug Safety 2009; 32 (9): 787-800

Prescribing Medications in Patients with Decompensated Liver Cirrhosis Deepak N.Amarapurkar etal; International Journal of Hepatology, 2011, page no-1-7

Justiniano Santos etal;Spironolactone alone or in combination with furosemide in thetreatment of moderate ascitis in nonazotemic cirrhosis; A randomized comparative study of efficacy and safety; Journal of Hepatology, volume39, 2003, 187–192.


  • There are currently no refbacks.